Discover 2,017 paid clinical trials in Michigan. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Michigan offers access to numerous clinical research opportunities for both healthy volunteers interested in paid studies and those with specific health conditions. Research hubs in Detroit, Grand Rapids, and Ann Arbor are enrolling participants, providing access to innovative treatments and personalized care options.
Filter
1
Filter results
Results: 2,017
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
for
Venous Thromboembolism, Deep Venous Thrombosis,
Location: Providence RI, New Haven CT, Bay Shore NY, Brooklyn NY,
Sponsor: Inari Medical
Sex: All
Age: 18+
Code: NCT05701917
Recruiting
PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)
for
Pancreatic Ductal Adenocarcinoma,
Location: Lake Success NY, Miami FL, Detroit MI, Houston TX,
Sponsor: PanTher Therapeutics
Sex: All
Age: 18+
Code: NCT06673017
Phase 1, Recruiting
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
for
Breast Neoplasms, Breast Cancer, Breast Tumors, Angiosarcoma,
Location: New Haven CT, The Bronx NY, New York NY,
Sponsor: QuantumLeap Healthcare Collaborative
Sex: All
Age: 18+
Code: NCT01042379
Phase 2, Recruiting
Chemotherapy Induced Peripheral Neuropathy Natural History Study (EPIPHANY)
for
Chemotherapy-induced Peripheral Neuropathy
Location: Burlington VT, Philadelphia PA, Baltimore MD,
Sponsor: Disarm Therapeutics
Sex: All
Age: 18+
Code: NCT03997981
Recruiting
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
Location: New York NY, Baltimore MD, Grand Rapids MI
Sponsor: Leiden University Medical Center
Sex: All
Age: 18+
Code: NCT06932081
Recruiting
To Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of DAY301 in Participants With Locally Advanced or Metastatic Solid Tumors
for
Advanced or Metastatic Solid Tumors
Location: New Haven CT, New York NY, Toronto, Sarasota FL,
Sponsor: Day One Biopharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06752681
Phase 1, Recruiting
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant